No Data
No Data
Hengrui Medicine's Unit Gets Nod to Trial Melanoma Drug
Express News | Jiangsu Hengrui Pharmaceuticals Says Co Plans to Issue 815.09 Mln H-Shares for Hong Kong Listing
Jiangsu Hengrui Medicine Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Do Its Financials Have Any Role To Play In Driving Jiangsu Hengrui Medicine Co., Ltd.'s (SHSE:600276) Stock Up Recently?
Hengrui Pharmaceutical: Hengrui Pharmaceutical Report for the First Quarter of 2025
Hengrui Pharmaceutical\'s 2025 First Quarter Report